Background. The NarcotrendÔ (Monitor Technik, Bad Bramstedt, Germany) assesses sedation by automatic classi®cation of EEG signals, using a scale ®rst used for visual evaluation of the EEG. Limited information is available on its value, and only a few studies of the method exist. We set out to study the performance of the NarcotrendÔ during propofol sedation.
As depth of sedation cannot be reliably judged by cardiovascular measurements alone, especially during total i.v. anaesthesia, 1 a reliable method is needed to measure the hypnotic component of sedation and anaesthesia. Hypnotic effects are associated with a slowing of the EEG signal, and processed EEG variables such as the Bispectral Index (BIS) or the spectral edge frequency were developed to ease EEG interpretation, which is time-consuming and requires special knowledge. 2 The NarcotrendÔ (Monitor Technik, Bad Bramstedt, Germany) is an EEG monitor. It was developed by a research group at the Hannover University Medical School (Germany) and uses algorithms for automatic assessment of the raw EEG during anaesthesia and sedation. 2 3 Two EEG channels are recorded comparing signals from the two hemispheres of the brain. After artefact detection, the EEG signals are automatically classi®ed, using multivariate statistical procedures, using a scale with six stages from A (awake) to F (general anaesthesia/coma) and 14 substages. 4 The stages are displayed on a computer monitor that also shows the raw signal EEG, the median frequency, the spectral edge frequency and a trend analysis.
We set out to test the ability of the NarcotrendÔ to assess sedation obtained with different propofol doses.
excluded patients with central nervous or cerebrovascular diseases, including poor hearing, those taking benzodiazepines or other centrally acting agents, those with a history of oesophageal re¯ux or a body mass index over 30. No premedication was given.
In the induction room we applied blood pressure, ECG and pulse oximeter monitors. The three EEG electrodes for the NarcotrendÔ (Version 2.0 AF; Monitor Technik) were applied to the forehead as recommended by the manufacturer. A full description of the NarcotrendÔ algorithm has been published. 5 Impedance was automatically checked and the electrodes repositioned if the value was greater than 6 kW. The range of the NarcotrendÔ stages and substages shown by the monitor are given in Table 1 . After recording the heart rate and blood pressure and the NarcotrendÔ stage, we set up a propofol infusion using a target-controlled infusion system (BD Pilot Anaesthesia; Becton Dickinson and Fresenius VIAL Medical, Brezins, France), with an initial target concentration of 0.5 mg ml ±1 . Considering the plasma effect±site equilibration half-time for propofol, 6±8 we took measurements 8 min after the target level of propofol had been set. The NarcotrendÔ stage was then recorded by one person and a clinical assessment of sedation, using the modi®ed Observer's Assessment of Alertness/Sedation Scale (OAA/S) ( Table 2) , was made by another person who was not aware of the monitor output. Of the four components of the OAA/S score, responsiveness was the chief characteristic used for assessing the sedation level. 9 10 The set concentration of propofol was increased incrementally to 1.0, 2.0, 3.0 and 4.0 mg ml ±1 and the sedation score and cardiovascular measurements were recorded at each stage.
At greater degrees of sedation, when the OAA/S scale failed, a noxious stimulus was applied with a peripheral nerve stimulator (NS 252; Fisher & Paykel, Auckland, New Zealand) using a tetanic stimulus with 50 Hz/50 mA for 10 s via ECG electrodes mounted over the tibia. 11 
Statistics
Statistical analysis was performed with SPSS 11.0 (SPSS, Chicago, IL, USA). The prediction probability P K was calculated to show the relationship between the anaesthetic depth indicator value (NarcotrendÔ stages) and the observed anaesthetic depth (OAA/S levels). The prediction probability P K is independent of scale units, it does not require knowledge of underlying distributions or efforts to linearize or transform scales, and is recommended as an appropriate measure for evaluating and comparing the performance of anaesthetic depth indicators. 12 We determined the P K and compared P K values with special software (PK/PKD MACROÔ; California State University, Sacramento, CA, USA) based on a standard calculation program (ExcelÔ, Microsoft). To describe the precision of the estimated prediction probability P K , the standard deviation of the estimate of P K was calculated, which in this statistical approach is called the standard error (SE) of the estimate of P K (personal communication, W. Smith, California State University, Sacramento, CA, USA). Spearman rank correlation analysis was performed with SPSS.
Results
Patients characteristics are shown in Table 3 . A total of 138 measurements were obtained, of which nine could not be interpreted because the signal quality was poor. The NarcotrendÔ failed to analyse the EEG of seven patients Does not respond to mild prodding or shaking ± ± ± 0 Does not respond to pain ± ± ± at target propofol concentrations of 0.0, 0.5, 1.0, and 2.0 mg ml ±1 . With all these measurements the OAA/S score was 4 or 5. In these lightly sedated patients, the signal could have been contaminated by electrical activity from muscles.
NarcotrendÔ and OAA/S scale
With increasing sedation indicated by the NarcotrendÔ levels, the OAA/S scores decreased signi®cantly (P<0.05). The NarcotrendÔ levels and the corresponding values of the OAA/S score for each patient and the median response are shown in Figure 1 . The prediction probability (P K ) value for the OAA/S scores in each patient ranged from 0.86 to 1.00. The overall value was 0.92 (SE 0.01), indicating a strong relationship between the NarcotrendÔ and OAA/S stages. This was supported by the Spearman correlation coef®cient (r=0.91). In addition, if the sedation scale is treated as an interval variable, linear regression analysis showed a positive correlation (R 2 =0.83, P<0.001), with the following relationship:
OAA/S=±0.51[NarcotrendÔ level]+5.35
Greater diversion of the OAA/S levels was seen at the NarcotrendÔ levels C (C0 to C2), indicating the light sleep phase that corresponded to target propofol concentrations 2.0 and 3.0 mg ml
±1
. In this range the prediction probability was fair, with a P K of 0.79 (SE 0.04) and a Spearman correlation coef®cient of r=0.66. Table 4 compares the NarcotrendÔ levels and the corresponding OAA/S levels. Considering patients with an OAA/S score of 1 or less as unconscious, 44 out of 129 observations indicated deep sedation or unconsciousness. Of these, 37 measurements matched the NarcotrendÔ levels D or E. Only in two measurements, a NarcotrendÔ level of D or E did not correspond with OAA/S scores of 1 or 0.
Considering awake patients, there were 68 OAA/S scores of 4 or 5, which indicate the awake state, and 66 of these corresponded to A or B levels of the NarcotrendÔ. In eight out of 74 cases, NarcotrendÔ levels of A or B were not associated with an OAA/S score of 4 or 5.
Sedation scales and target concentration of propofol
The prediction probability (P K ) values of the NarcotrendÔ levels for the target propofol concentration in each patient ranged from 0.80 to 1.00 with a mean P K of 0.92 (SE 0.01) and a Spearman correlation coef®cient of r=0.92. Figure 2 shows the NarcotrendÔ levels and the corresponding values of the target propofol concentration for each patient and the median response.
We found an almost linear relationship between the mean target concentrations of propofol and the NarcotrendÔ. The P K calculated to re¯ect the predictive performance of target propofol concentrations for the OAA/S levels was P K =0.93 (SE 0.01). The Spearman correlation coef®cient was r=0.91. Table 4 Assessment of OAA/S and NarcotrendÔ levels in all patients (number of patients). Cells shaded light grey show the numbers of patients in whom NarcotrendÔ and OAA/S both indicated unconsciousness or being awake. An OAA/S score of`1 and a NarcotrendÔ level`D0 were considered as unconscious. Cells shaded dark grey indicate disagreement; for example, when the NarcotrendÔ indicated an awake patient with a level of B2 whereas the OAA/S indicated a score of 1 (unconscious) OAA/S score Narcotrend TM level Total NarcotrendÔ measurement of depth of sedation Figure 3 shows the percentage of patients who were unconscious (OAA/S score <2) at given target concentrations of propofol. When the mean target concentration of propofol exceeded 3 mg ml ±1 , 86% of the patients were unconscious, while at 4 mg ml ±1 all patients were unconscious. Figure 3 shows that at target concentrations of propofol between 1 and 4 mg ml ±1 , the NarcotrendÔ identi®es fewer patients as unconscious than the OAA/S score.
Mean arterial pressure, heart rate and OAA/S scale To compare cardiovascular measurements, which are often used to detect light stages of anaesthesia, with the OAA/S score we estimated the prediction probability (P K ) for mean arterial pressure (MAP) and heart rate. The P K value for the MAP was 0.69 (SE 0.04) and for the heart rate it was 0.51 (SE 0.04). Direct comparison of the P K values for NarcotrendÔ levels, MAP and heart rate showed that the NarcotrendÔ levels gave a signi®cantly higher prediction probability.
Discussion
Devices to estimate anaesthetic depth from EEG signals are currently of interest. They may help prevent underdosage and awareness, and also avoid overdosage and allow faster recovery. 13 The bispectral index and other measures have been studied frequently but only a few studies have been published so far on the NarcotrendÔ, a monitor recently available in Europe. 2 14 ±16 We tested if the NarcotrendÔ could correctly assess the depth of propofol sedation and anaesthesia. Depth of anaesthesia can be assessed clinically using measures such as heart rate, blood pressure, sweating, tear formation and pupil size, 17 but these do not indicate the level of consciousness directly. Because measures of anaesthetic depth such as the BIS lack the required validity to be used as a gold standard, we used clinical judgement as a measure, with the OAA/S scale, which is reliable and valid. 9 We found that the NarcotrendÔ level was a good predictor of the patient's state of clinical sedation and correlated well with the responsiveness score. NarcotrendÔ levels also predicted speci®c target concentrations of propofol (P K =0.916) and correlated well with these. There was no difference in the ability of the NarcotrendÔ levels and the target concentrations of propofol to predict the clinical sedation. This was not found in other studies, 10 18 in which the responsiveness score correlated signi®cantly better with the BIS score (r=0.883) than the targeted or measured concentration of propofol (r=±0.778).
Ordinal values from a responsiveness rating scale may not give a linear relation between the observed effect and other measures of anaesthetic depth. 12 To account for this dif®culty, prediction probability has been proposed as a measure of the performance of such depth measurements. The good correlation between the NarcotrendÔ levels and the responsiveness score and the excellent prediction probability values indicate that the NarcotrendÔ is a good measure of sedation and loss of consciousness. The NarcotrendÔ predicted the responsiveness of the patient with a mean probability of 92%.
Some studies have already compared the predictive performance of the NarcotrendÔ and BIS monitoring. Liu and colleagues reported good correlation between BIS and clinical criteria of sedation. 19 NarcotrendÔ and BIS monitoring corresponded well during increasing depth of anaesthesia with propofol and remifentanil.
14 Both NarcotrendÔ and BIS monitoring can reduce recovery times and propofol dosage during general anaesthesia. 5 During emergence from anaesthesia, both NarcotrendÔ and BIS monitoring correlated signi®cantly with a target concentration of propofol, but failed to assess the level of consciousness when a remifentanil infusion was given simultaneously. Because monitoring devices for anaesthetic depth may not always be available, we also analysed the relationship between traditional markers for the responsiveness of anaesthetized patients. P K values for mean arterial pressure and heart rate were less than 0.70 and failed to predict the level of sedation. As well as anaesthetic depth, other factors, such as blood volume and cardiac contractility, will affect the autonomic responses to stimuli, 1 so the autonomic effects of propofol are likely to vary widely during sedation.
We found that a target propofol concentration of 4 mg ml ±1 is needed to obtain unconsciousness reliably in all patients. At given concentrations of propofol, the NarcotrendÔ identi®ed fewer patients as unconscious than the responsiveness score. This suggests high speci®city for adequate depth of anaesthesia, but our data do not allow such an analysis. Assessment of the level of sedation by the OAAS/ S score and the NarcotrendÔ levels diverges at low target concentrations of propofol, because at 2.0 and 3.0 mg ml
±1
we observed the greatest differences in the prediction probability values. In this range, the averaged predictive performance was only 79%. Clinically unrecognizable excitation during initial sedation by propofol could cause these differences, and these could vary between patients depending on age, weight and other factors. More studies of EEG-derived measures, such as BIS and NarcotrendÔ levels, are needed for the lighter levels of anaesthesia. By reducing anaesthetic dosage to the minimum required to provide adequate anaesthetic depth, overdosage can be prevented and a decrease in cost is possible. By monitoring the depth of remifentanil-supplemented propofol anaesthesia with BIS or NarcotrendÔ, emergence from anaesthesia was speeded up by 60% and consumption of propofol was reduced by 30%. 5 In a multicentre comparison of 4630 patients with and without the NarcotrendÔ, the NarcotrendÔ speeded emergence from total i.v. anaesthesia when compared with patients managed without NarcotrendÔ analysis. 16 The NarcotrendÔ can reliably distinguish between wakefulness and anaesthesia but lacks accuracy in assessing the intermediate stages. Possible advantages compared with other devices, such as the BIS, remain to be demonstrated. Better understanding of EEG patterns in relation to anaesthetic agents and the effects of opioids and other anaesthetics may indicate the value of the NarcotrendÔ monitor.
